Published in Thromb Haemost on October 18, 1993
Recent developments in nitric oxide donor drugs. Br J Pharmacol (2007) 1.94
Retracted Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties. Oxid Med Cell Longev (2015) 1.40
Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances. ACS Chem Biol (2011) 1.12
Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP. Cell Cycle (2010) 1.04
Improving Blood Compatibility of Intravascular Oxygen Sensors Via Catalytic Decomposition of S-Nitrosothiols to Generate Nitric Oxide In Situ. Sens Actuators B Chem (2007) 0.95
Nitric oxide-releasing/generating polymers for the development of implantable chemical sensors with enhanced biocompatibility. Talanta (2007) 0.92
A randomized clinical trial testing the anti-inflammatory effects of preemptive inhaled nitric oxide in human liver transplantation. PLoS One (2014) 0.82
NO supplementation for transfusion medicine and cardiovascular applications. Future Sci OA (2016) 0.75
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med (1990) 5.91
Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med (1991) 3.80
Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem (1991) 3.27
Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med (1994) 2.80
Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J Am Coll Cardiol (2000) 2.61
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res (2001) 2.33
Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease. JAMA (1997) 2.17
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol (2000) 2.05
Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation (1993) 1.90
Cardiac sympathetic nerve function in congestive heart failure. Circulation (1996) 1.84
Translation and cultural adaptation of health questionnaires. J Pak Med Assoc (2003) 1.82
Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation (1993) 1.81
Cerebellar leukoencephalopathy: most likely histiocytosis-related. Neurology (2008) 1.73
Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation (1994) 1.66
The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis (2000) 1.66
Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation (1994) 1.65
Endothelial progenitor cells as putative targets for angiostatin. Cancer Res (1999) 1.63
Role of nitric oxide in the vasodilator response to mental stress in normal subjects. Am J Cardiol (1997) 1.61
Morphology of ambulatory ST segment changes in patients with varying severity of coronary artery disease. Investigation of the frequency of nocturnal ischaemia and coronary spasm. Br Heart J (1985) 1.58
The secondary amine/nitric oxide complex ion R(2)N[N(O)NO](-) as nucleophile and leaving group in S9N)Ar reactions. J Org Chem (2001) 1.57
Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol (1995) 1.56
Inability of the ST segment/heart rate slope to predict accurately the severity of coronary artery disease. Br Heart J (1984) 1.56
Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J Am Coll Cardiol (1992) 1.55
Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem (1996) 1.54
Reversible parkinsonism and MRI diffusion abnormalities in cortical venous thrombosis. Neurology (2001) 1.53
Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing: importance of the exercise protocol. J Am Coll Cardiol (1991) 1.52
Front-line management of pulmonary tuberculosis: an analysis of tuberculosis and treatment practices in urban Sindh, Pakistan. Tuber Lung Dis (1996) 1.48
Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol (2001) 1.48
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation (1994) 1.45
Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J Med Chem (1997) 1.44
Balloon tamponade for control of massive presacral haemorrhage. Br J Surg (1996) 1.44
Assessment of liquid captopril formulations used in children. Arch Dis Child (2010) 1.44
Incidence of spasm at the site of previous successful transluminal coronary angioplasty: effect of ergometrine maleate in consecutive patients. Br Heart J (1986) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. J Am Chem Soc (2001) 1.42
Mechanisms of nocturnal angina pectoris: importance of increased myocardial oxygen demand in patients with severe coronary artery disease. Lancet (1984) 1.41
Role of Bi-pap in acute respiratory failure due to acute exacerbation of COPD. J Pak Med Assoc (2001) 1.39
Acute vascular effects of estrogen in postmenopausal women. Circulation (1994) 1.39
Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension (1997) 1.38
A study of the influence of insulin resistance on left ventricular mass in hypertensive patients. J Assoc Physicians India (2000) 1.38
Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation (1995) 1.38
The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation (1993) 1.36
Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol. Br Med J (Clin Res Ed) (1984) 1.35
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Aspirin improves endothelial dysfunction in atherosclerosis. Circulation (1998) 1.27
Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol (1999) 1.25
Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation (2001) 1.24
Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials (2000) 1.23
Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action. Toxicol Appl Pharmacol (2000) 1.23
Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. Am J Cardiol (1995) 1.22
Emergence of low level vancomycin resistance in MRSA. Indian J Med Microbiol (2007) 1.22
Tetrahydrobiopterin: a novel antihypertensive therapy. J Hum Hypertens (2008) 1.21
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
A new approach to measuring estrogen exposure and metabolism in epidemiologic studies. J Steroid Biochem Mol Biol (2010) 1.19
Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension (1997) 1.18
Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res (1993) 1.17
Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation (2000) 1.14
The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation (1997) 1.14
In vivo radiation protection by nitric oxide modulation. Cancer Res (1994) 1.13
Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction. Hypertension (1998) 1.12
Ambulatory electrocardiographic ST segment changes in healthy volunteers. Br Heart J (1983) 1.12
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Deliv Rev (2001) 1.12
Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity. J Med Chem (2000) 1.11
Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53. Oncogene (2008) 1.10
Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders. Int Rev Psychiatry (2005) 1.10
Re: BJL Kendrick, CA Pailthorpe, E Powell-Smith. Iatrogenic ulna fracture following Kirschner wire fixation of a distal radius fracture in a 98-year-old lady. J Hand Surg Eur. 2012, 37: 579-81. J Hand Surg Eur Vol (2013) 1.08
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
Value of the bipolar lead CM5 in electrocardiography. Br Heart J (1986) 1.08
Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res (1993) 1.07
Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol Heart Circ Physiol (2001) 1.07
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol (1990) 1.05
Nitric oxide-releasing polymers containing the [N(O)NO]- group. J Med Chem (1996) 1.05
Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest (1995) 1.03
Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. J Am Coll Cardiol (1997) 1.02
Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol (1993) 1.02
Eales' disease: diagnosis and management. Eye (Lond) (2010) 1.02
Liver tumorigenesis by Helicobacter hepaticus: considerations of mechanism. In Vivo (1996) 1.01
Deamination of single-stranded DNA cytosine residues in aerobic nitric oxide solution at micromolar total NO exposures. Chem Res Toxicol (1996) 1.01
Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J Drug Target (1995) 1.00
DNA sequence changes induced by two nitric oxide donor drugs in the supF assay. Chem Res Toxicol (1995) 1.00
Ontogeny of apoptosis during lung development. Pediatr Res (1998) 1.00
Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele. Blood Cells Mol Dis (2002) 0.99
Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol (1993) 0.99
Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response. Circulation (2000) 0.98
Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockade. Circ Res (2001) 0.98
Neural substrates of word generation during stroke recovery: the influence of cortical hypoperfusion. Behav Neurol (2007) 0.97
N-nitrosation by nitrite ion in neutral and basic medium. Science (1973) 0.97
Myocardial ischemia--silent or symptomatic. N Engl J Med (1988) 0.97
Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. Nitric Oxide (1997) 0.96
Measurement of form-factor-independent observables in the decay B0→K(*0)μ(+)μ(-). Phys Rev Lett (2013) 0.96
Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability. J Am Coll Cardiol (1999) 0.96
Observation of a resonance in B+ → K+ μ+ μ- decays at low recoil. Phys Rev Lett (2013) 0.95
Rhinosporidiosis of the parotid duct presenting as a parotid duct cyst - a report of three cases. Indian J Med Microbiol (2012) 0.95
N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol (2001) 0.94
Nitric oxide induces metallothionein (MT) gene expression apparently by displacing zinc bound to MT. Toxicol Lett (2001) 0.94
Differences in clinical presentation of pulmonary tuberculosis in association with age. J Pak Med Assoc (2003) 0.94
Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine. Circulation (1992) 0.93
Admissions with atrial fibrillation in a multiracial population in Kuala Lumpur, Malaysia. Int J Cardiol (2003) 0.93